参考文献/References:
[1] ZHU C,LI S,GAO X,et al.Retrospective analysis of thyroid nodules:thyroid cancer risk factors in Suzhou,China[J].Clin Lab,2018,64(3):333-338.
[2] 王苏,姜孝奎,武文杰,等.精细被膜解剖技术在分化型甲状腺癌手术中的应用[J].新乡医学院学报,2017,34(7):690-692,696.
[3] 种静,孙咏梅,张俊鹏,等.超声造影对甲状腺乳头状癌的诊断价值[J].中国医学影像学杂志,2017,25(4):241-245.
[4] GOU Q,GAO L,NIE X,et al.Long noncoding RNA AB074169 inhibits cell proliferation via modulation of KHSRP-mediated CDKN1a expression in papillary thyroid carcinoma[J].Cancer Res,2018,78(15):4163-4174.
[5] 殷德涛,韩飏,张亚原,等.多灶性甲状腺乳头状癌的临床病理及颈淋巴结转移特征[J].中国普通外科杂志,2017,26(5):556-560.
[6] CHEN B,LI J,YI C,et al.Long non-coding RNA POLR2E rs3787016 is associated with the risk of papillary thyroid carcinoma in Chinese population[J].Pathol Res Pract,2018,214(7):1040-1044.
[7] 丁颖丽,霍艳雷,王丹阳,等.儿童及青少年分化型甲状腺癌放射性碘治疗进展[J].中华实用儿科临床杂志,2018,33(8):631-634.
[8] 任庆余,王琳杰,赵进沛.碘-131治疗分化型甲状腺癌外照射辐射剂量研究[J].中国职业医学,2017,44(5):625-628.
[9] AMDUR R J,DAGAN R.The University of Florida Department of Radiation Oncology Guidelines for treatment of differentiated thyroid cancer with I-131 or external-beam radiotherapy[J].Am J Clin Oncol,2018,[Epub ahead of print].
[10] PACINI F,BASOLO F,BELLANTONE R,et al.Italian consensus on diagnosis and treatment of differentiated thyroid cancer:joint statements of six Italian societies[J].J Endocrinol Invest,2018,41(7):849-876.
[11] 黎颖昕,弓健,郭斌,等.分化型甲状腺癌患者131I治疗后胸腺显影伴甲状腺球蛋白升高的临床分析[J].中国医学影像技术,2017,33(7):985-988.
[12] LI R,DONG B,WANG Z,et al.MicroRNA-361-5p inhibits papillary thyroid carcinoma progression by targeting ROCK1[J].Biomed Pharmacother,2018,102:988-995.
[13] STEFANESCU H,MUNTEAN D,PILUT C,et al.Using blood and plasma MicroRNAs as a non-invasive biomarker in patients with colorectal cancer[J].Clin Lab,2018,64(3):257-262.
[14] LUAN T,ZOU R,HUANG L,et al.Hsa-miR-3658 promotes cell proliferation,migration and invasion by effecting LASS2 in bladder cancer[J].Clin Lab,2018,64(4):515-525.
[15] CHEN Z,ZHAO L,SHI K,et al.Mechanism comparison of gemcitabine and dasatinib-resistant pancreatic cancer by integrating mRNA and miRNA expression profiles[J].Clin Lab,2018,64(5):749-757.
[16] 姜炜博.miRNA-495通过HMGN5对骨肉瘤生物学行为影响的研究[D].长春:吉林大学,2017.
[17] JIN Y,TAO L P,YAO S C,et al.MicroRNA-582-5p suppressed gastric cancer cell proliferation via targeting AKT3[J].Eur Rev Med Pharmacol Sci,2017,21(22):5112-5120.
[18] JIN X,GUAN Y,SHENG H,et al.Crosstalk in competing endogenous RNA network reveals the complex molecular mechanism underlying lung cancer[J].Oncotarget,2017,8(53):91270-91280.
[19] WANG W W,CHEN B,LEI C B,et al.miR-582-5p inhibits invasion and migration of salivary adenoid cystic carcinoma cells by targeting FOXC1[J].Jpn J Clin Oncol,2017,47(8):690-698.
[20] SHU Z,CHEN L,DING D.miR-582-5P induces colorectal cancer cell proliferation by targeting adenomatous polyposis coli[J].World J Surg Oncol,2016,14(1):239-245.
[21] 郝义,孙笑,刘玉秋,等.miRNA-146a在视网膜色素上皮细胞老化及老年性黄斑变性中的功能研究[J].眼科新进展,2017,37(2):117-121.
[22] LI J,XU J,YAN X,et al.microRNA-485 plays tumour-suppressive roles in colorectal cancer by directly targeting GAB2[J].Oncol Rep,2018,40(1):554-564.
[23] LIU C,SU C,CHEN Y,et al.MiR-144-3p promotes the tumor growth and metastasis of papillary thyroid carcinoma by targeting paired box gene 8[J].Cancer Cell Int,2018,18:54-66.
[24] HUANG P,MAO L F,ZHANG Z P,et al.Down-regulated miR-125a-5p promotes the reprogramming of glucose metabolism and cell malignancy by increasing levels of CD147 in thyroid cancer[J].Thyroid,2018,28(5):613-623.
相似文献/References:
[1]赵艳利,康志强,毛 雨,等.微RNA-152靶向调控内质网脂质Raft关联蛋白1对甲状腺乳头状癌细胞增殖和迁移的影响[J].新乡医学院学报,2021,38(9):801.[doi:10.7683/xxyxyxb.2021.09.001]
ZHAO Yanli,KANG Zhiqiang,MAO Yu,et al.Effect of microRNA-152 on proliferation and migration of papillary thyroid carcinoma cells by targeting endoplasmic reticulum lipid raft associated protein 1[J].Journal of Xinxiang Medical University,2021,38(11):801.[doi:10.7683/xxyxyxb.2021.09.001]
[2]郭艳风,韩芳毅,周红艳,等.L型氨基酸转运体1和血管内皮生长因子在甲状腺乳头状癌中的表达及意义[J].新乡医学院学报,2017,34(1):036.[doi:10.7683/xxyxyxb.2017.01.010]
GUO Yan-feng,HAN Fang-yi,ZHOU Hong-yan,et al.Expressions of L-type amino acid transporter 1 and vascular endothelial growth factor in papillary thyroid carcinoma and their clinical significance[J].Journal of Xinxiang Medical University,2017,34(11):036.[doi:10.7683/xxyxyxb.2017.01.010]